Cancer cell associated glycans as targets for immunotherapy. (2016)
Attributed to:
Improving the functional affinity of human anti-glycan monoclonal antibodies (mabs) for cancer therapy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1080/2162402x.2015.1061177
PubMed Identifier: 26942075
Publication URI: http://europepmc.org/abstract/MED/26942075
Type: Journal Article/Review
Volume: 5
Parent Publication: Oncoimmunology
Issue: 1
ISSN: 2162-4011